We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana Inks Deal to Offer Value-Based Care to MA Members
Read MoreHide Full Article
Humana Inc. (HUM - Free Report) recently announced its value-based agreement with The University of Chicago Medicine (UChicago Medicine), dedicated to provide a better and more coordinated patient-centered experience to Humana Medicare Advantage (MA) members.
With this collaboration, both organizations share a commitment to improve the average health outcomes of members in the Chicago land area. It will provide an access to members enrolled in Humana Health Maintenance Organization (HMO), Preferred Provider Organization and Private Fee-for-Service health plan members, to avail health care services at the University of Chicago Medical Center along with UChicago Medicine outpatient care centers and clinics plus the University of Chicago Physicians Group practices.
This tie-up with The University of Chicago Medicine would enable Humana to use the academic medical institution’s 90 years of experience in the community. The company would share its data-driven insights and proficiency to provide a high-quality yet cost-effective patient care in Illinois. Patients will be able to spend more personal time with health professionals and get tailored care depending on the uniqueness and complications of their health conditions. Members with chronic cases are also expected to get more focused care, thus helping them achieve optimum health results.
Humana’s Value-Based Care Profile
Humana possesses an extensive value-based care presence. It has signed an agreement with University of Louisville Physicians earlier in August for boosting an in-network access to Humana Medicare HMO members at UofL Physicians primary care and specialty clinics in Kentucky.
In June 2018, the company entered into an agreement with Monida Healthcare Network to provide its Medicare Advantage members with access to five-member hospitals. Last year, Humana inked a value-based deal with Community Care Physicians (“CCP”) in New York for allowing in-network access to Humana’s Medicare Advantage members at CCP facilities.
As of Jun 30, 2018, it had around two million individual Medicare Advantage members and 130,000 Group members, treated by more than 52,000 primary care physicians in above 1,000 value-based relationships across 43 states and Puerto Rico. Patients receive better care while providers are able to increase their revenues through these plans.
Shares of Humana have surged 30.1% in a year’s time, underperforming its industry’s rally of 34.3%. It holds a Zacks Rank #3 (Hold).
Stocks to Consider
Investors interested in the Medical-HMO industry can also check out some better-ranked stocks like UnitedHealth Group Incorporated (UNH - Free Report) , Anthem, Inc. and WellCare Health .
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It carries a Zacks Rank #2 (Buy) and came up with an average four-quarter positive earnings surprise of 3.71%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Anthem operates as a health benefits company in the United States and is a Zacks #2 Ranked player. It managed to pull off an average trailing four-quarter earnings surprise of 6.65%.
WellCare provides managed care services for government-sponsored health care programs. The company holds an impressive Zacks Rank of 2 and came up with an average four-quarter beat of 53.89%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Humana Inks Deal to Offer Value-Based Care to MA Members
Humana Inc. (HUM - Free Report) recently announced its value-based agreement with The University of Chicago Medicine (UChicago Medicine), dedicated to provide a better and more coordinated patient-centered experience to Humana Medicare Advantage (MA) members.
With this collaboration, both organizations share a commitment to improve the average health outcomes of members in the Chicago land area. It will provide an access to members enrolled in Humana Health Maintenance Organization (HMO), Preferred Provider Organization and Private Fee-for-Service health plan members, to avail health care services at the University of Chicago Medical Center along with UChicago Medicine outpatient care centers and clinics plus the University of Chicago Physicians Group practices.
This tie-up with The University of Chicago Medicine would enable Humana to use the academic medical institution’s 90 years of experience in the community. The company would share its data-driven insights and proficiency to provide a high-quality yet cost-effective patient care in Illinois. Patients will be able to spend more personal time with health professionals and get tailored care depending on the uniqueness and complications of their health conditions. Members with chronic cases are also expected to get more focused care, thus helping them achieve optimum health results.
Humana’s Value-Based Care Profile
Humana possesses an extensive value-based care presence. It has signed an agreement with University of Louisville Physicians earlier in August for boosting an in-network access to Humana Medicare HMO members at UofL Physicians primary care and specialty clinics in Kentucky.
In June 2018, the company entered into an agreement with Monida Healthcare Network to provide its Medicare Advantage members with access to five-member hospitals. Last year, Humana inked a value-based deal with Community Care Physicians (“CCP”) in New York for allowing in-network access to Humana’s Medicare Advantage members at CCP facilities.
As of Jun 30, 2018, it had around two million individual Medicare Advantage members and 130,000 Group members, treated by more than 52,000 primary care physicians in above 1,000 value-based relationships across 43 states and Puerto Rico. Patients receive better care while providers are able to increase their revenues through these plans.
Shares of Humana have surged 30.1% in a year’s time, underperforming its industry’s rally of 34.3%. It holds a Zacks Rank #3 (Hold).
Stocks to Consider
Investors interested in the Medical-HMO industry can also check out some better-ranked stocks like UnitedHealth Group Incorporated (UNH - Free Report) , Anthem, Inc. and WellCare Health .
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It carries a Zacks Rank #2 (Buy) and came up with an average four-quarter positive earnings surprise of 3.71%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Anthem operates as a health benefits company in the United States and is a Zacks #2 Ranked player. It managed to pull off an average trailing four-quarter earnings surprise of 6.65%.
WellCare provides managed care services for government-sponsored health care programs. The company holds an impressive Zacks Rank of 2 and came up with an average four-quarter beat of 53.89%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>